cdocker in discovery studio 2017 r2 (Accelrys)
90
Structured Review
Accelrys
cdocker in discovery studio 2017 r2
Cdocker In Discovery Studio 2017 R2, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdocker+in+discovery+studio+2017+r2/cdocker+in+discovery+studio+2017+r2/pm40199026-309-13-22
Average 90 stars, based on 1 article reviews
Cdocker In Discovery Studio 2017 R2, supplied by Accelrys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdocker+in+discovery+studio+2017+r2/cdocker+in+discovery+studio+2017+r2/pm40199026-309-13-22
Average 90 stars, based on 1 article reviews
cdocker in discovery studio 2017 r2 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Discovery of 2,4-dianilinopyrimidine derivatives as novel p90 ribosomal S6 protein kinase (RSK) inhibitors. Article Snippet: RSK, or p90 ribosomal S6 kinase, plays a crucial role in tumor cell proliferation and survival, making it an appealing target for cancer therapies.. With the aim to explore novel RSK inhibitors as anticancer agents, a series of 2,4-dianilinopyrimidine derivatives 2b–2n and 3a–3n have been designed and synthesized.. Among them, compound 3e displayed substantial kinase inhibitory activity against RSK2 (IC50 = 37.89 ± 3.08 nM) and a potent antiproliferative effect against a range of cell lines, including HeLa, MIA PaCa-2, U937, SW620, HT-29, AGS, and two kinds of EGFR mutant cells (IC50s = 0.189–0.572 μM). |